Bimodal distribution of renal cytochrome P450 3A activity in humans

Molecular Pharmacology

Volumn 50, Issue 1, 1996, Pages 52-59

  Haehner, Barbara D ^a,d   Gorski, J Christopher ^a   Vandenbranden, Mark ^b   Wrighton, Steven A ^b   Janardan, Srinivas K ^c   Watkins, Paul B ^c   Hall, Stephen D ^a  

^a INDIANA UNIVERSITY   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d WISHARD MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA HYDROXYMIDAZOLAM; CYTOCHROME P450; KIDNEY ENZYME; MESSENGER RNA; MIDAZOLAM; TROLEANDOMYCIN;

ARTICLE; CATALYSIS; CONTROLLED STUDY; DRUG HYDROXYLATION; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY MICROSOME; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION;

ANTIBODIES; CYTOCHROME P-450 CYP2E1; CYTOCHROME P-450 ENZYME SYSTEM; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; IMMUNOBLOTTING; KIDNEY; KIDNEY CORTEX; KIDNEY MEDULLA; KIDNEY NEOPLASMS; MALE; MICROSOMES; MICROSOMES, LIVER; MIDAZOLAM; MIXED FUNCTION OXYGENASES; RNA, MESSENGER; TESTICULAR NEOPLASMS; TRANSCRIPTION, GENETIC; TROLEANDOMYCIN;

EID: 0030006845     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. McGiff, J. C., C. P. Quilley, and M. A. Carroll. The contribution of cytochrome P450-dependent arachidonate metabolites to integrated renal function. Steroids 58:573-579 (1993).
2. Schuetz, E. G., J. D. Schuetz, W. L, Grogan, A. Naray, F. Toth, G. F. Toth, J. Raucy, P. Guzelian, K. Gionela, and C. O. Watlington. Expression of cytochrome P450 3A in amphibian, rat, and human kidney. Arch. Biochem. Biophys. 294:206-214 (1992).
3. Leggat, J. E., K. J. Johnson, J. C. Kolars, P. Schmiedlin-Ren, P. B. Watkins, and A. B. Leightman. Immunohistochemical localization of cytochrome P4503A in normal and neoplastic kidney and urinary bladder epithelium. J. Am Soc. Nephrol. 5:786 (1994).
4. Waxman, D. J., C. Attisano, P. F. Guengerich, and D. P. Lapenson. Human liver microsomal steroid metabolism: identification of the major microsomal steroid 6β-hydroxylase cytochrome P450 enzyme. Arch. Biochem. Biophys. 263:242-436 (1988).
5. Wrighton, S. A., W. R. Brian, M. Sari, M. Iwasaki, F. P. Guengerich, J. L. Raucy, D. T. Molowa, and M. VandenBranden. Studies on the expression and metabolic capabilities of human liver cytochromes P450 3A5 (HLP 3). Mol. Pharmacol. 38:207-213 (1990).
6. Duncan, R. L., W. M. Grogan, L. B. Kramer, and C. O. Watlington. Corticosterones' metabolite is an agonist for sodium transport stimulation in A6 cells. Am. J. Physiol. 225:F736-F748 (1988).
7. Grogan, W. M., V. M. Phillips, E. G. Schuetz, P. S. Guzelian, and C. O. Watlington. Corticoaterone 6β-hydroxylase in A6 epithelia a steroid inducible cytochrome P450. Am. J. Physiol. 258:C480-C488 (1990).
8. Ghosh, S., W. M. Grogan, A. Basu, and C. O. Watlington. Renal corticosterone 6β-hydroxylase in the spontaneously hypertensive rat. Biochim. Biophys. Acta 1182:152-156 (1993).
9. Watlington, C. O., L. B. Kramer, E. G. Schuetz, W. Zilai, W. M. Grogan, P. Guzelian, G. Gizek, and A. Schoolwerth. Corticosterone 6β-hydroxylation correlates with blood pressure in spontaneously hypertensive rats. Am. J. Physiol. 262:F927-F931 (1992).
10. Levere, R. D., P. Martasek, B. Escalente, M. L. Schwartzman, and N. G. Abraham. Effect of homoarginate administration on blood pressure in spontaneously hypertensive rats. J. Clin. Invest. 86:213-219 (1990).
11. Sacerdoti, D. B., B. Escalente, N. G. Abraham, J. C. McGiff, R. D. Levere, and M. L. Schwartzman. Treatment with tin prevents the development of hypertension in the spontaneously hypertensive rat. Science (Washington D. C.) 243:388-390 (1989).
12. Funae, Y., R. Seo, and S. Imaoka. Multiple forms of cytochrome P450 from microsomes of rat liver, kidney lung by HPLC. Biochem. Intern. 11:523-531 (1985).
13. Lowry, O. H., N. H. Rosenbrough, A. L. Farr, and F. J. Randall. Protein measurement with Folin phenol reagent. J. Biol. Chem. 193:265-275 (1951).
14. Gorski, J. C., S. D. Hall, D. R. Jones, M. VandenBranden, and R. Wrighton. Regioselective biotransformation of midazolam by members of the human CYP3A subfamily. Biochem. Pharmacol. 47:1643-1653 (1994).
15. Gorski, J. C., D. R. Jones, S. A. Wrighton, and S. D. Hall. Characterization of dextromethorophan N-demethylation by human liver microsomes. Biochem. Pharmacol. 48:173-182 (1994).
16. Kolars, J. C., K. S. Lown, P. Schmiedlin-Ren, M. Ghosh, C. Fang, S. A. Wrighton, R. M. Merion, and P. B. Watkins. CYP3A gene expression in human gut epithelium. Pharmacogenetics 4:247-259 (1994).
17. Chomczynski, P., and N. Sacchi. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159 (1987).
18. Endrenyi, L., and M. Patel. A new sensitive graphical method for detecting deviations from the normal distribution of drug responses: the NTV plot. Br. J. Clin. Pharmacol. 32:159-166 (1991).
19. Buters, J. T., K. R. Korzekwa, K. L. Kunze, Y. Omata, P. Hardwick, and F. J. Gonzalez. cDNA-directed expression of human cytochrome P450 using baculovirus. Drug Metab. Dispos. 22:688-692 (1994).
20. Schwartzman, M. L., P. Martasek, A. R. Rios, R. D. Levere, K. Solangi, A. L. Goodman, and N. G. Abraham. Cytochrome P450-dependent arachidonic acid metabolism in human kidney. Kidney Int. 37:94-99 (1990).
21. Imig, J. D., A. P. Zou, P. O. DeMontellano, Z. Sui, and R. J. Roman. Cytochrome p-450 inhibitors alter afferent arteriolar responses to elevations in pressure. Am. J. Physiol. 266:H1879-H1885 (1994).
22. Lipman, M. M., F. H. Katz, and J. W. Jailer. An alternative pathway for cortisol metabolism: 6β-hydroxycortisol production by human tissue slices. J. Clin. Endocrinol. Metab. 22:268-272 (1962).
23. Jenkins, J. S. Metabolism of cortisol by the human adrenal cortex in vitro. J. Clin. Endocrinol. Metab. 25:649-654 (1965).
24. Katz, F. H., M. M. Lipman, A. G. Franz, and J. W. Jailer. The physiologic significance of 6β-hydroxycortisol in human corticoid metabolism. J. Clin. Endocrinol. 22:71-77 (1962).
25. Dienvenu, T., E. Rey, G. Pons, P, D'Athis, and G. Olive. A simple noninvasive procedure for the investigation of cytochrome P450 IIIA dependent enzymes in humans. Int. J. Clin. Pharmacol. Ther. Toxicol. 29:441-445 (1991).
26. Watkins, P. B., S. A. Wrighton, E. G. Scheutz, D. T. Molowa, and P. S. Guzelian. Identification of glucocorticoid inducible CYP450 in intestinal mucosa of rats and man. J. Clin Invest. 80:1029-1036 (1987).
27. Ged, C., J. Rouillon, L. Pichard, J. Combalbert, N. Bressot, P. Bories, H. Michel, P. Beaune, and P. Maurel. The increase in urinary excretion of 6β-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction. Br. J. Clin. Pharmacol. 28:373-387 (1989).
28. Watkins, P. B., D. K. Turgeon, P. Saenger, K. Lown, J. Kolars, T. Hamilton, K. Fishman, P. Guzelian, and J. J. Voorhees. Comparison of urinary 6β-hydroxycortisol and the erythromycin breath test as measures of hepatic P450IIIA (CYP3A) activity. Clin. Pharmacol. Ther. 52:265-273 (1992).
29. Kinirons, M. T., D. O'Shea, T. E. Downing, A. T. Fitzwilliam, L. Joellenbeck, J. D. Groopman, G. R. Wilkinson, and A. J. Wood. Absence of correlations among three putative in vivo probes of human cytochrome P4503A activity in young healthy men. Clin. Pharmacol. Ther. 54:621-629 (1993).
30. Kishida, S., and D. Fukushima. Radioimmunoassay of 6β-hydroxycortisol in plasma and urine. Steroids 30:741-740 (1977).
31. Perkins, F. M., and J. S. Handler. Transport properties of toad kidney epithelia in culture. Am. J. Physiol. 241:C154-C159 (1981).
32. Watlington, C. O., J. Atkins, J. McNeil, W. Grogan, and J. Johnson. Corticosterone is converted to 6β-hydroxycorticosterone in rat: effects of the metabolite on urinary electrolyte excretion. J. Steroid Biochem. 31: 947-954 (1988).
33. Clore, J. N., H. Estep, H. Ross-Clunis, and C. O. Watlington. Adrenocorticotropin and cortisol induced changes in urinary sodium and potassium excretion in man: effects of spironolactone and RU486. J. Clin. Endocrinol. Metab. 67:824-831 (1988).
34. Kronbach, T., D. Mathys, M. Umeno, F. Gonzolez, and U. Meyer. Oxidation of midazolam and triazolam by human liver cytochrome P450 IIIA. Mol. Pharmacol. 38:89-96 (1990).
35. Schuetz, E. G., J. D. Schuetz, S. C. Strom, M. T. Thompson, R. A. Fisher, D. T, Molowa, D. Li, and P. S. Guzelian. Regulation of human liver cytochrome P460 3A in primary and continuous culture of human hepatocytes. Hepatology 18:1254-1262 (1993).